What We're Reading: Page 14
Industry reads hand-picked by our editors
Sep 11, 2025
-
Associated Press
Trump’s plan for a drug advertising crackdown faces many hurdles
-
The Wall Street Journal
Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women
-
Reuters
Private equity firm Advent to sell drugmaker Zentiva to GTCR
Sep 10, 2025
-
The New York Times
Trump Weighs Crackdown on Medicines From China
-
Bloomberg
Fired CDC Director to Testify in Senate on Turmoil at the Agency
-
404 Media
HHS Asks All Employees to Start Using ChatGPT
Sep 09, 2025
Sep 08, 2025
-
Axios
China pharma deals threaten U.S. biotech
-
The New York Times
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87
-
The Wall Street Journal
The Billionaires Fueling the Quest for Longer Life
-
NPR
This is what could happen to a child who doesn’t get vaccinated
Sep 05, 2025
-
Bloomberg
BioZorb Breast Cancer Device Injuries Were Kept Secret for Years
-
FirstWord Pharma
Study success for DualityBio’s ADC boosts BioNTech’s oncology ambitions
-
BioCentury
Rep. Auchincloss challenges FDA’s new priority voucher program
-
Stat
Donavon Decker knew a gene therapy experiment wouldn’t help him. To help others, he still said yes
Sep 04, 2025
-
The Boston Globe
National consensus on vaccines, COVID boosters, unravels
-
The Washington Post
FDA questions safety of receiving covid, flu vaccines together
-
Bloomberg
Novo Tests Ozempic Pill as Possible Alzheimer’s, Dementia Drug
-
Pink Sheet
US FDA Compounding Advisory Panel Hit Hardest By Recent Purges
Previous
